Literature DB >> 26595183

Homology modeling of parasite histone deacetylases to guide the structure-based design of selective inhibitors.

Jelena Melesina1, Dina Robaa1, Raymond J Pierce2, Christophe Romier3, Wolfgang Sippl4.   

Abstract

Histone deacetylases (HDACs) are promising epigenetic targets for the treatment of various diseases, including cancer and neurodegenerative disorders. There is evidence that they can also be addressed to treat parasitic infections. Recently, the first X-ray structure of a parasite HDAC was published, Schistosoma mansoni HDAC8, giving structural insights into its inhibition. However, most of the targets from parasites of interest still lack this structural information. Therefore, we prepared homology models of relevant parasitic HDACs and compared them to human and S. mansoni HDACs. The information about known S. mansoni HDAC8 inhibitors and compounds that affect the growth of Trypanosoma, Leishmania and Plasmodium species was used to validate the models by docking and molecular dynamics studies. Our results provide analysis of structural features of parasitic HDACs and should be helpful for selecting promising candidates for biological testing and for structure-based optimisation of parasite-specific inhibitors.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epigenetics; Histone deacetylases; Homology modeling; Molecular docking; Molecular modeling; Parasitic diseases

Mesh:

Substances:

Year:  2015        PMID: 26595183     DOI: 10.1016/j.jmgm.2015.10.006

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  11 in total

1.  Cyclic Tetrapeptide HDAC Inhibitors with Improved Plasmodium falciparum Selectivity and Killing Profile.

Authors:  Jennifer E Collins; Jin Woo Lee; Monica J Bohmer; Joshua D Welden; Arash K Arshadi; Lin Du; Robert H Cichewicz; Debopam Chakrabarti
Journal:  ACS Infect Dis       Date:  2021-09-07       Impact factor: 5.578

2.  One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasites.

Authors:  Daniela Diedrich; Katharina Stenzel; Eva Hesping; Yevgeniya Antonova-Koch; Tamirat Gebru; Sandra Duffy; Gillian Fisher; Andrea Schöler; Stephan Meister; Thomas Kurz; Vicky M Avery; Elizabeth A Winzeler; Jana Held; Katherine T Andrews; Finn K Hansen
Journal:  Eur J Med Chem       Date:  2018-09-07       Impact factor: 6.514

3.  Structure-Activity and Structure-Toxicity Relationships of Peptoid-Based Histone Deacetylase Inhibitors with Dual-Stage Antiplasmodial Activity.

Authors:  Marcel K W Mackwitz; Eva Hesping; Yevgeniya Antonova-Koch; Daniela Diedrich; Tamirat Gebru Woldearegai; Tina Skinner-Adams; Mary Clarke; Andrea Schöler; Laura Limbach; Thomas Kurz; Elizabeth A Winzeler; Jana Held; Katherine T Andrews; Finn K Hansen
Journal:  ChemMedChem       Date:  2019-02-19       Impact factor: 3.466

4.  In silico identification of inhibitors against Plasmodium falciparum histone deacetylase 1 (PfHDAC-1).

Authors:  Amarjeet Kumar; Suman Kumar Dhar; Naidu Subbarao
Journal:  J Mol Model       Date:  2018-08-14       Impact factor: 1.810

5.  Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth.

Authors:  Ming Jang Chua; Megan S J Arnold; Weijun Xu; Julien Lancelot; Suzanne Lamotte; Gerald F Späth; Eric Prina; Raymond J Pierce; David P Fairlie; Tina S Skinner-Adams; Katherine T Andrews
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2016-12-23       Impact factor: 4.077

6.  Molecular Modeling and Structural Stability of Wild-Type and Mutant CYP51 from Leishmania major: In Vitro and In Silico Analysis of a Laboratory Strain.

Authors:  Masoud Keighobadi; Saeed Emami; Milad Lagzian; Mahdi Fakhar; Alireza Rafiei; Reza Valadan
Journal:  Molecules       Date:  2018-03-19       Impact factor: 4.411

7.  Histone deacetylase enzymes as potential drug targets of Neglected Tropical Diseases caused by cestodes.

Authors:  Hugo R Vaca; Ana M Celentano; Natalia Macchiaroli; Laura Kamenetzky; Federico Camicia; Mara C Rosenzvit
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2019-02-23       Impact factor: 4.077

Review 8.  Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability.

Authors:  Giorgio Milazzo; Daniele Mercatelli; Giulia Di Muzio; Luca Triboli; Piergiuseppe De Rosa; Giovanni Perini; Federico M Giorgi
Journal:  Genes (Basel)       Date:  2020-05-15       Impact factor: 4.096

9.  The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs.

Authors:  Hugo Rolando Vaca; Ana María Celentano; María Agustina Toscanini; Tino Heimburg; Ehab Ghazy; Patrik Zeyen; Alexander-Thomas Hauser; Guilherme Oliveira; María Celina Elissondo; Manfred Jung; Wolfgang Sippl; Federico Camicia; Mara Cecilia Rosenzvit
Journal:  PLoS Negl Trop Dis       Date:  2021-03-03

Review 10.  Molecular Structure, Binding Affinity, and Biological Activity in the Epigenome.

Authors:  Balázs Zoltán Zsidó; Csaba Hetényi
Journal:  Int J Mol Sci       Date:  2020-06-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.